Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species
Mouse (Murine) IGFBP4 ELISA Kit for Sandwich ELISA - ABIN365447
Talbot, Sparks, Powell, Kahl, Caperna: Quantitative and semiquantitative immunoassay of growth factors and cytokines in the conditioned medium of STO and CF-1 mouse feeder cells. in In vitro cellular & developmental biology. Animal 2012
Data show that insulin-like growth factor binding protein-4 (IGFBP-4) was significantly elevated in lupus nephritis, particularly those with renal pathology chronicity changes.
The present study provides the first evidence that apoptosis inhibitor of macrophages binds to IGFBP2 (show IGFBP2 ELISA Kits), 3 and 4.
Data show that co-transfection with cDNA encoding stanniocalcin-1 (show STC1 ELISA Kits) abrogates the proteolytic activity of pregnancy-associated plasma protein-A (PAPP-A (show PAPPA ELISA Kits)) toward IGF-binding protein 4 (IGFBP-4).
PLasma IGFBP-4 levels are not acutely altered following myocardial infarction treated with heparin and percutaneous coronary intervention.
High IGFBP-4 fragment levels were associated with increased all-cause and cardiovascular mortality rates in T1D patients with and without diabetic nephropathy.
Data indicate co-localization of insulin (show INS ELISA Kits)-like growth factor binding proteins IGFBP-4, IGFBP-5 (show IGFBP5 ELISA Kits) in the syncytiotrophoblast layer of first trimester placental villi as early as 5 weeks of gestational age.
IGF-1 (show IGF1 ELISA Kits)/IGFbp4 signaling regulated the post-developmental adipose tissue expansion.
Despite the relation of CT-IGFBP4 to a more severe coronary artery disease, CT- and NT-IGFBP4, in contrast to our report based on total PAPP-A (show PAPPA ELISA Kits), failed to predict any long-term outcomes in patients with stable cardiovascular disease.
these findings demonstrate an oncogenic property for IBP (show TSPO ELISA Kits) in promoting the metastatic potential of breast cancer cells.
PAPP-A (show PAPPA ELISA Kits) and IGFBP-4 gene expression (microarray analysis) was significantly upregulated in IL-1beta (show IL1B ELISA Kits)- or TNF-alpha (show TNF ELISA Kits)-exposed cells.
exerts a negative effect on basal intestinal growth but plays a positive regulatory role in the intestinotropic actions of GLP-2
Igfbp2 (show IGFBP2 ELISA Kits)-5 are expressed in distinct and complementary patterns during cochlear development.
SOX9 (show SOX9 ELISA Kits) is a transcriptional regulator of IGFBP-4 and that SOX9 (show SOX9 ELISA Kits)-induced activation of IGFBP-4 may be one of the mechanisms by which SOX9 (show SOX9 ELISA Kits) suppresses cell proliferation and progression of colon cancer.
findings indicate that the defect in p53 function and the increased proteolysis of IGFBP-4, we had observed, represent two components of the same pathway, which contributes to the oncogenic function of Skp2B
Inactivation of IGFBP4 diminished the anabolic effects of PAPP-A (show PAPPA ELISA Kits) on bone.
Targeted expression of a protease-resistant IGFBP-4 mutant in smooth muscle of transgenic mice
IGFBP-4 is a potential growth inhibitor of lymphoid tissues.
This study demonstrates that ES of muscle cells in vitro not only directly modulates the gene expression of contractile proteins but also modulates proteins that are part of the IGF regulatory system, in particular IGFBP-4.
Crystallization, heparin and IGF binding (show HTRA1 ELISA Kits), and osteogenic activity of IGFBP4 in its native conformation
follicular dominance was associated with low or decreased follicular fluid concentrations of IGFBP-4 and -5
Sequence analysis showed that the porcine IBP4 gene encodes a protein of 259 amino acids which shares high homology with the insulin-like growth factor binding protein 4 (IBP4) of eight species.
This gene is a member of the insulin-like growth factor binding protein (IGFBP) family and encodes a protein with an IGFBP domain and a thyroglobulin type-I domain. The protein binds both insulin-like growth factors (IGFs) I and II and circulates in the plasma in both glycosylated and non-glycosylated forms. Binding of this protein prolongs the half-life of the IGFs and alters their interaction with cell surface receptors.
insulin-like growth factor binding protein 4
, IGF-binding protein 4
, insulin-like growth factor-binding protein 4
, Band 3A
, differentially expressed in B16F10 2
, insulin-like growth factor binding protein-4